<p>The present invention relates to pharmacodynamic markers for CDKIs including the candidate 2, 6, 9-tri-substituted purine known as roscovitine. The identity of these markers facilitates the convenient identification of roscovitine-like activity both in vitro and in vivo.</p>
申请公布号
WO2004087955(A1)
申请公布日期
2004.10.14
申请号
WO2004GB01337
申请日期
2004.03.26
申请人
CYCLACEL LIMITED;CANCER RESEARCH TECHNOLOGY LIMITED;GREEN, SIMON, R.;WORKMAN, PAUL;WHITTAKER, STEVEN, R.
发明人
GREEN, SIMON, R.;WORKMAN, PAUL;WHITTAKER, STEVEN, R.
